[Epithelial-mesenchymal transition in fibrosing processes. Mesothelial cells obtained ex vivo from patients treated with peritoneal dialysis as transdifferentiation model].
Selgas
R
R
Servicio de Nefrología del Hospital Universitario de La Princesa, Madrid. rselgas.hlpr@salud.madrid.org
Bajo
Ma A
MA
Aguilera
A
A
Sánchez-Tomero
J A
JA
Cirugeda
A
A
del Peso
G
G
Alvarez
V
V
Jiménez-Heffernan
J A
JA
Díaz
C
C
López-Cabrera
M
M
D015415:Biomarkers / Q000032:analysis; D002454:Cell Differentiation; D002465:Cell Movement; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D039421:Integrin alpha2 / Q000096:biosynthesis; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007375:Interleukin-1 / Q000494:pharmacology; D008233:Lymphotoxin-alpha / Q000494:pharmacology; D008648:Mesoderm / Q000166:cytology* / Q000187:drug effects / Q000473:pathology; D010530:Peritoneal Dialysis; D010537:Peritoneum / Q000166:cytology* / Q000473:pathology; D010641:Phenotype
D015415:Biomarkers; D039421:Integrin alpha2; D007375:Interleukin-1; D008233:Lymphotoxin-alpha; D018799:Intercellular Adhesion Molecule-1